Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent meningococcal conjugate vaccine in Japanese adults ≥56 years
jRCT1061190014Active, not recruiting
- Sponsor
- Ministry of Health, Labour and Welfare
- Start
- Dec 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of meningococcal (groups A, C, Y, and W-135) polysaccharide conjugate vaccine in meningococcal disease, sponsored by Ministry of Health, Labour and Welfare. Primary endpoint: Immunogenicity and safety. Started Dec 2017; status: active, not recruiting.
02
Drugs
meningococcal (groups A, C, Y, and W-135) polysaccharide conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on jRCT1061190014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061190014.